Clinical Value Dashboard
Select a population and compare which diagnostic or treatment strategy provides the best modeled value.
Current scenario
General US adults
Cohort
10,000
Perspective
Healthcare system
Time horizon
1 yr
WTP
$100k/QALY
Estimated iron deficiency cases
1,200
12.0% of 10,000 patients
Best diagnostic strategy
Ferritin ≤50 ng/mL
1,056 detected · 144 missed
Best treatment strategy
Upfront IV iron
8,740 responders modeled
Highest-value pathway
Aggressive detection and faster treatment
1,092 detected · 1,092 treated
Recommended next view
Diagnose Iron Deficiency
Begin by comparing diagnostic strategies for this population.
Diagnose Iron Deficiency
Compare testing strategies
Select Treatment Strategy
Compare treatment pathways
High-Risk Populations
Population-specific pathways
Diagnose Iron Deficiency
Favored
Ferritin ≤50 ng/mL
Key driver
Balances detection with acceptable false-positive burden
Uncertainty: Moderate
Select Treatment Strategy
Favored
Upfront IV iron
Key driver
Balances oral therapy cost with escalation for non-response
Uncertainty: Moderate
High-Risk Populations
Favored
Aggressive detection and faster treatment
Key driver
Reduces missed cases where delayed treatment costs more
Uncertainty: Higher
Strategy value summary
Value score for the best-modeled option in each module at the current WTP threshold.
Cost vs clinical benefit
Lower-left = lower cost with lower benefit; upper-right = higher cost with higher benefit.
Results are generated from an illustrative demonstration model and should not be interpreted as final clinical, policy, or economic conclusions.